Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Prospective, Multi-center Phase I/II Trial of Lenalidomide and Dose-Adjusted EPOCH-R in MYC-Associated B-Cell Lymphomas

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02213913
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:15.196891+00:00
Published At
2026-03-11T00:00:00+00:00
Record Updated At
2026-03-11
Results Posted At
2026-03-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Adult Grade III Lymphomatoid Granulomatosis", "B-cell Chronic Lymphocytic Leukemia", "Contiguous Stage II Adult Diffuse Large Cell Lymphoma", "Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma", "Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma", "Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma", "Contiguous Stage II Grade 1 Follicular Lymphoma", "Contiguous Stage II Grade 2 Follicular Lymphoma", "Contiguous Stage II Grade 3 Follicular Lymphoma", "Contiguous Stage II Mantle Cell Lymphoma", "Contiguous Stage II Marginal Zone Lymphoma", "Contiguous Stage II Small Lymphocytic Lymphoma", "Cutaneous B-cell Non-Hodgkin Lymphoma", "Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue", "Intraocular Lymphoma", "Nodal Marginal Zone B-cell Lymphoma", "Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma", "Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma", "Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma", "Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma", "Noncontiguous Stage II Grade 1 Follicular Lymphoma", "Noncontiguous Stage II Grade 2 Follicular Lymphoma", "Noncontiguous Stage II Grade 3 Follicular Lymphoma", "Noncontiguous Stage II Mantle Cell Lymphoma", "Noncontiguous Stage II Marginal Zone Lymphoma", "Noncontiguous Stage II Small Lymphocytic Lymphoma", "Progressive Hairy Cell Leukemia, Initial Treatment", "Small Intestine Lymphoma", "Splenic Marginal Zone Lymphoma", "Stage 0 Chronic Lymphocytic Leukemia", "Stage I Adult Diffuse Large Cell Lymphoma", "Stage I Adult Diffuse Mixed Cell Lymphoma", "Stage I Adult Diffuse Small Cleaved Cell Lymphoma", "Stage I Adult Hodgkin Lymphoma", "Stage I Adult Immunoblastic Large Cell Lymphoma", "Stage I Chronic Lymphocytic Leukemia", "Stage I Grade 1 Follicular Lymphoma", "Stage I Grade 2 Follicular Lymphoma", "Stage I Grade 3 Follicular Lymphoma", "Stage I Mantle Cell Lymphoma", "Stage I Marginal Zone Lymphoma", "Stage I Small Lymphocytic Lymphoma", "Stage II Adult Hodgkin Lymphoma", "Stage II Chronic Lymphocytic Leukemia", "Stage II Small Lymphocytic Lymphoma", "Stage III Adult Diffuse Large Cell Lymphoma", "Stage III Adult Diffuse Mixed Cell Lymphoma", "Stage III Adult Diffuse Small Cleaved Cell Lymphoma", "Stage III Adult Hodgkin Lymphoma", "Stage III Adult Immunoblastic Large Cell Lymphoma", "Stage III Chronic Lymphocytic Leukemia", "Stage III Grade 1 Follicular Lymphoma", "Stage III Grade 2 Follicular Lymphoma", "Stage III Grade 3 Follicular Lymphoma", "Stage III Mantle Cell Lymphoma", "Stage III Marginal Zone Lymphoma", "Stage III Small Lymphocytic Lymphoma", "Stage IV Adult Diffuse Large Cell Lymphoma", "Stage IV Adult Diffuse Mixed Cell Lymphoma", "Stage IV Adult Diffuse Small Cleaved Cell Lymphoma", "Stage IV Adult Hodgkin Lymphoma", "Stage IV Adult Immunoblastic Large Cell Lymphoma", "Stage IV Chronic Lymphocytic Leukemia", "Stage IV Grade 1 Follicular Lymphoma", "Stage IV Grade 2 Follicular Lymphoma", "Stage IV Grade 3 Follicular Lymphoma", "Stage IV Mantle Cell Lymphoma", "Stage IV Marginal Zone Lymphoma", "Stage IV Small Lymphocytic Lymphoma", "Testicular Lymphoma", "Untreated Hairy Cell Leukemia", "Waldenstr\u00f6m Macroglobulinemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-11"
protocolSection.identificationModule.nctId
"NCT02213913"
protocolSection.identificationModule.officialTitle
"Prospective, Multi-center Phase I/II Trial of Lenalidomide and Dose-Adjusted EPOCH-R in MYC-Associated B-Cell Lymphomas"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-03-11"

Study condition terms

  • Adult Grade III Lymphomatoid Granulomatosis (protocolSection.conditionsModule.conditions)
  • B-cell Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Contiguous Stage II Adult Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Contiguous Stage II Grade 1 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Contiguous Stage II Grade 2 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Contiguous Stage II Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Contiguous Stage II Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Contiguous Stage II Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
  • Contiguous Stage II Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
  • Cutaneous B-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue (protocolSection.conditionsModule.conditions)
  • Intraocular Lymphoma (protocolSection.conditionsModule.conditions)
  • Nodal Marginal Zone B-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Noncontiguous Stage II Grade 1 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Noncontiguous Stage II Grade 2 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Noncontiguous Stage II Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Noncontiguous Stage II Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Noncontiguous Stage II Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
  • Noncontiguous Stage II Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
  • Progressive Hairy Cell Leukemia, Initial Treatment (protocolSection.conditionsModule.conditions)
  • Small Intestine Lymphoma (protocolSection.conditionsModule.conditions)
  • Splenic Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage 0 Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Stage I Adult Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Adult Diffuse Mixed Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Adult Diffuse Small Cleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Adult Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Adult Immunoblastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Stage I Grade 1 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Grade 2 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage II Adult Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage II Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Stage II Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Adult Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Adult Diffuse Mixed Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Adult Diffuse Small Cleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Adult Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Adult Immunoblastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Stage III Grade 1 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Grade 2 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Adult Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Adult Diffuse Mixed Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Adult Diffuse Small Cleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Adult Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Adult Immunoblastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Stage IV Grade 1 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Grade 2 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
  • Testicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Untreated Hairy Cell Leukemia (protocolSection.conditionsModule.conditions)
  • Waldenström Macroglobulinemia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.